What is the recommended evaluation and management—including acute and preventive therapy—for abdominal migraine presenting as recurrent mid‑abdominal pain with nausea and vomiting?

Abdominal Migraine: Evaluation and Management

For abdominal migraine presenting as recurrent mid-abdominal pain with nausea and vomiting, start with ibuprofen for acute attacks and add an antiemetic if nausea is prominent; if attacks are frequent (≥2 per month) or disabling, initiate preventive therapy with propranolol, topiramate, or amitriptyline combined with cognitive behavioral therapy. 1

Diagnostic Approach

Abdominal migraine is a clinical diagnosis requiring:

• Paroxysmal episodes of moderate-to-severe midline or periumbilical abdominal pain lasting hours to days
• Associated symptoms: nausea, vomiting, pallor, anorexia, photophobia
• Complete symptom freedom between attacks (this is critical—persistent symptoms suggest another diagnosis)
• Personal or family history of migraine (present in most cases)
• Peak age 7 years, though can occur in adolescents and adults 2, 3, 4

Key evaluation points:

• Selective or no testing is needed once diagnostic criteria are met 4
• Rule out red flags: fever, weight loss, GI bleeding, nocturnal symptoms, abnormal physical exam
• Most patients will develop typical migraine headaches later in life 5, 2

Acute Treatment Algorithm

First-Line: NSAIDs

Ibuprofen 400-800 mg at attack onset is the primary acute treatment 1. Early treatment improves efficacy 6.

Add Antiemetic for Nausea/Vomiting

• Metoclopramide or prochlorperazine should be used liberally—nausea itself is disabling and warrants treatment even without vomiting 7, 6
• Consider non-oral routes if vomiting is prominent 7

Second-Line: Triptans (Adolescents)

If ibuprofen fails after 3 consecutive attacks, consider:

• Sumatriptan nasal spray
• Zolmitriptan nasal spray
• Rizatriptan ODT 1

Non-oral formulations are preferred given the GI symptoms. If one triptan fails, try another 1.

What NOT to Use

Avoid opioids and butalbital-containing compounds—they lead to dependency, rebound headaches, and loss of efficacy 6, 8, 6

Preventive Therapy

Indications for Prevention

Consider preventive therapy when:

• ≥2 attacks per month causing disability
• Acute treatments fail or are contraindicated
• Acute medication overuse (≥10 days/month for triptans, ≥15 days/month for NSAIDs) 8, 7

First-Line Preventive Options

Critical counseling point: Discuss with families that placebo was as effective as medication in many pediatric trials 1. This shared decision-making is essential.

Recommended agents:

1. Propranolol 80-240 mg/day 7, 9
2. Topiramate 500-1500 mg/day (discuss teratogenic effects; require effective contraception and folate supplementation in females of childbearing potential) 7, 1
3. Amitriptyline 30-150 mg/day combined with cognitive behavioral therapy 1

Start low, titrate slowly. Clinical benefit may take 2-3 months to manifest—give adequate trial before abandoning 7.

Second-Line Options

• Candesartan 9
• Flunarizine (where available) 7, 9
• Divalproex sodium 500-1500 mg/day (contraindicated in females of childbearing potential) 7

Emerging Options

Recent evidence suggests gepants (rimegepant, atogepant) may be beneficial in refractory pediatric cases, though this is based on real-world data rather than RCTs 10. Consider only after multiple preventive failures.

Non-Pharmacologic Management

Essential first-line interventions:

• Trigger avoidance (identify through headache diary)
• Lifestyle modifications: regular sleep schedule, consistent meals, adequate hydration, regular aerobic exercise, stress management 8, 1
• Cognitive behavioral therapy (particularly effective when combined with amitriptyline) 1
• Patient education and reassurance about benign nature and expected resolution 4

Monitoring and Follow-Up

• Headache diary tracking attack frequency, severity, duration, disability, treatment response, and adverse effects 7
• Reevaluate therapy regularly 7
• After period of stability, consider tapering preventive medication 7
• Medication overuse headache is a critical pitfall—monitor acute medication frequency closely 8

Common Pitfalls

1. Misdiagnosis: Failing to recognize symptom-free intervals between attacks (suggests functional dyspepsia or other DGBI instead)
2. Overuse of acute medications: Leads to medication overuse headache and treatment failure
3. Premature abandonment of preventive therapy: Need 2-3 month trial before declaring failure
4. Using acetaminophen alone: No evidence for efficacy in migraine 6, 7
5. Prescribing opioids: Creates dependency without addressing underlying pathophysiology 8